Pavlovic Drasko, Salehi Tania, Piccoli Giorgina B, Coates Patrick T
Polyclinic for Internal Medicine and Dialysis B. Braun Avitum, Zagreb, Croatia.
Central Northern Adelaide Renal and Transplantation Service, Adelaide, Australia.
Clin Kidney J. 2022 Apr 7;15(8):1622-1625. doi: 10.1093/ckj/sfac089. eCollection 2022 Aug.
The history of renal replacement therapy (RRT) for end-stage kidney disease (ESKD) started in 1960 and has reached, in these six decades, goals initially unforeseen. This report describes two patients who commenced dialysis at the age of 17 and 27, for 53 and 45 years, respectively, whereby the modality of RRT was mostly in the form of home haemodialysis. The history of these two patients, who started RRT in distant parts of the world, Australia and Croatia, highlights not only the advances made over time, to significantly delay the onset and reduce the morbidity and mortality associated with ESKD, but also underlines the importance of empowerment and commitment, added values in home haemodialysis.
终末期肾病（ESKD）的肾脏替代治疗（RRT）始于1960年，在这六十年间，实现了最初未曾预见的目标。本报告描述了两名分别在17岁和27岁开始透析的患者，透析时间分别为53年和45年，其RRT模式主要为家庭血液透析。这两名在世界遥远地区澳大利亚和克罗地亚开始接受RRT治疗的患者的经历，不仅凸显了随着时间推移所取得的进展，即显著延迟ESKD的发病并降低其发病率和死亡率，还强调了自主能力和投入的重要性，以及家庭血液透析的附加价值。
